Market pulse › Lerodalcibep
Lerodalcibep
Today2 stories · 10 articles
Net tone▲ +100% today
Market checkSun Pharma −0.8%
Developing0 storylines
128 Sept
129 Sept
Broker call▲ bullishSun Pharma Lerodalcibep Deal: Macquarie Sees Cross-Selling Opportunities, Maintains 'Outperform' CallSun Pharma will pursue regulatory approvals in licensed territories where approval has not yet been obtainedSun PharmaPharma and healthcare
Deal▲ bullishSun Pharma secures rights to commercialise Lerodalcibep outside the US and ChinaSun Pharma will commercialise and manufacture Lerodalcibep worldwide, excluding the United States and ChinaSun PharmaPharma and healthcareChina